Thank you for participating in ChinaBio® Partnering Forum 2016

Download your messages and statistics, bookmark and set notifications to track your leads, all on partnering360®.

The majority of ChinaBio® Partnering Forum 2016 delegates are already members of partnering360®.

partnering360: maximize your productivity by engaging and finding partners 24/7. Synchronize your in-person partnering with your online activity — all in one place.

Tell us about your ChinaBio® Partnering Forum experience ►
 

Save the date and check back in the coming weeks for information on next year's ChinaBio® Partnering Forum, May 2017 in China.

 ChinaBio® Partnering Forum 2016 | May 18-19, 2016 | Suzhou, China

Please select your organization type / 请选择您所属机构:


Chinese Language /  中文

English Language / 英文

 

Videos of sessions from prior ChinaBio® Partnering Forums in China:

Western pharma's strategic role in China Western pharma's strategic role in China
April 15, 2015
Senior executives from global pharma examine how the rapidly changing landscape in China is driving their companies to adapt new R&D models to address the local market needs.
 
 

 
Biologics: China's new wave of innovation Biologics: China's new wave of innovation
April 15, 2015
Founders and senior executives from four of China's most innovative biologics companies will discuss where biologics innovation stands now and how it is evolving in the future.
 
 

 
The top seven challenges in structuring China-related
transactions The top seven challenges in structuring China-related transactions
April 16, 2015
Experts with significant China-Western cross-border transaction experience share the top seven negotiating challenges they have faced in China, and how these were resolved.
 
 

 
In- and out-licensing in China: A guide to success In- and out-licensing in China: A guide to success
April 15, 2015
For Western companies, in-licensing assets to the Chinese market creates a great opportunity. For Chinese companies, out-licensing creates significant leverage with Western life sciences.
 
 

 
Changing roles of Western pharma in China Changing roles of Western pharma in China
May 7, 2014
The rapidly changing landscape in China is driving pharma companies to adapt new R&D models to address local market needs and add dedicated BD teams to seek partners in China.
 
 

 
Top deals dissected: Where are
they now? Top deals dissected: Where are they now?
May 8, 2014
Of the 400 partnering deals in China in the last five years, 85% of the pharma deals were cross-border. BD and R&D executives explore the partnerships they have helped put together.
 
 

 
VC funding in China: Who's got the money
and how do you get it? VC funding in China: Who's got the money and how do you get it?
May 7, 2014
VC investment activity in life science companies in China was nearly USD 1 billion in 2013, including funding from international and domestic VCs, and the government.
 
 

 
Executive interview: A returnee's perspective Executive interview: A returnee's perspective
May 8, 2014
Dr. Steve Yang brings a unique perspective on the changes in the China life science industry he and WuXi have brought about, especially from a cross-border perspective.
 
 

 

 

Partnering Login

Please log in to the partneringONE® system.

CBPF2015 Highlights

   1262 one-to-one meetings
   858  attendees
  366 licensing opportunities posted
  435 companies
  16 exhibitors
   50 company presentations
   22 countries represented
   10 workshops and panels represented

Organizers